Literature DB >> 28895540

Polymorphism rs3123554 in the cannabinoid receptor gene type 2 (CNR2) reveals effects on body weight and insulin resistance in obese subjects.

Daniel Antonio de Luis1, Olatz Izaola2, David Primo2, Beatriz de la Fuente2, Rocio Aller2.   

Abstract

BACKGROUND: Few studies assessing the relationship between single nucleotide polymorphisms in CNR2 and obesity or its related metabolic parameters are available.
OBJECTIVE: To investigate the influence of polymorphism rs3123554 in the CNR2 receptor gene on obesity anthropometric parameters, insulin resistance, and adipokines in subjects with obesity.
DESIGN: The study population consisted of 1027 obese subjects, who were performed bioelectrical impedance analyses, blood pressure measurements, serial assessments of dietary intake during three days, and biochemical tests.
RESULTS: Genotypes GG, GA, and AA were found in 339 (33.0%), 467 (45.5%), and 221 (21.5%) respectively. Body mass index, weight, fat mass, waist circumference, insulin, HOMA-IR, and triglyceride and leptin levels were higher in A-allele carriers as compared to non A-allele carriers. No differences were seen in these parameters between the GA and AA genotypes. There were no statistical differences in dietary intake.
CONCLUSION: The main study finding was the association of the minor allele of the SNP rs3123554 in the CNR2 gene with body weight and triglyceride, HOMA-IR, insulin, and leptin levels.
Copyright © 2017 SEEN y SED. Publicado por Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Adipocinas; Adipokines; Cannabinoid receptor gene type 2; Gen del receptor canabinoide de tipo 2; Insulin resistance; Obesidad; Obesity; Polimorfismo; Polymorphism; Resistencia a la insulina

Mesh:

Substances:

Year:  2017        PMID: 28895540     DOI: 10.1016/j.endinu.2017.06.001

Source DB:  PubMed          Journal:  Endocrinol Diabetes Nutr        ISSN: 2530-0164


  5 in total

1.  Variability in cannabinoid receptor genes is associated with psychiatric comorbidities in anorexia nervosa.

Authors:  Luz María González; Angustias García-Herráiz; Sonia Mota-Zamorano; Isalud Flores; David Albuquerque; Guillermo Gervasini
Journal:  Eat Weight Disord       Date:  2021-02-11       Impact factor: 4.652

2.  The association of quantitative insulin sensitivity indices (HOMA-IR and QUICKI) with anthropometric and cardiometabolic indicators in adolescents.

Authors:  Yaser Mirzaalian; Mozhgan Nourian; Maryam Gholamalizadeh; Saeid Doaei; Mahshid Hatami; Akbar Hassanzadeh; Gholamreza Askari; Raheleh Farahi
Journal:  Arch Med Sci Atheroscler Dis       Date:  2019-04-09

Review 3.  What Role Does the Endocannabinoid System Play in the Pathogenesis of Obesity?

Authors:  Piotr Schulz; Szymon Hryhorowicz; Anna Maria Rychter; Agnieszka Zawada; Ryszard Słomski; Agnieszka Dobrowolska; Iwona Krela-Kaźmierczak
Journal:  Nutrients       Date:  2021-01-26       Impact factor: 5.717

Review 4.  Role of Cannabinoids in Obesity.

Authors:  Francesca Rossi; Francesca Punzo; Giuseppina Rosaria Umano; Maura Argenziano; Emanuele Miraglia Del Giudice
Journal:  Int J Mol Sci       Date:  2018-09-10       Impact factor: 5.923

5.  Evaluation of common variants in the CNR2 gene and its interaction with abdominal obesity for osteoporosis susceptibility in Chinese post-menopausal females.

Authors:  W Zheng; C Liu; M Lei; Y Han; X Zhou; C Li; S Sun; X Ma
Journal:  Bone Joint Res       Date:  2019-12-03       Impact factor: 5.853

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.